There are 2949 resources available
Second victim: How to support cancer nurses after a harmful event
Presenter: René Schwendimann
Session: EONS13: Quality and safety of cancer nursing
Resources:
Slides
Webcast
Invited Discussant LBA32 and 807O
Presenter: Ana Oaknin
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Isabelle Ray-Coquard
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Webcast
1O - A study of cancer dissemination from metastatic intermediates of hypermethylated colorectal patients reveals a new mode of collective migration
Presenter: Emmanuel Dornier
Session: Proffered Paper - Basic Science
Resources:
Abstract
Slides
Webcast
1977O - Functional inactivation of E-cadherin drives EMT-less metastasis
Presenter: Saverio Alberti
Session: Proffered Paper - Basic Science
Resources:
Abstract
Slides
Webcast
2O - Growth differentiation factor 15 (GDF-15) neutralization reverses cancer cachexia, restores physical performance and mitigates emesis associated with platinum-based chemotherapy
Presenter: Zhidan Wu
Session: Proffered Paper - Basic Science
Resources:
Abstract
Slides
Webcast
3O - Efficacy of the triple combination of Estrogen Receptor, CDK4/6 and PI3K pathway inhibitors in ex-vivo models of breast cancer
Presenter: Anna Diana
Session: Proffered Paper - Basic Science
Resources:
Abstract
Slides
Webcast
700O - Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N)
Presenter: Maxime Meylan
Session: Proffered Paper - GU, non prostate 2
Resources:
Abstract
Slides
Webcast
807O - Nivolumab versus gemcitabine or pegylated liposomal doxorubicin for patients with platinum-resistant (advanced or recurrent) ovarian cancer: Open-label, randomized trial in Japan (NINJA trial)
Presenter: Kohei Omatsu
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Abstract
Slides
Webcast
805O - ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or primary peritoneal carcinoma treatment
Presenter: Andrew Clamp
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Abstract
Slides
Webcast